ArticleJournal of clinical medicine2019

The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042.

Francisco Hermida-Prado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.